Table 4.
Group | TNF-α, pg/mL | RANTES, pg/mL | MCP-1, ng/mL |
---|---|---|---|
C |
39.07 [37.57 to 41.3] {34.38 to 45.42} |
923.45 [848.06 to 970.8] {724.55 to 1085.3} |
1.05 [0.91 to 1.19] {0.85 to 1.3} |
T |
61.68 [56.53 to 65.2] {53.99 to 76.35} |
1000.2 [958.35 to 1098.6] {817.2 to 1263.8} |
1.85 [1.56 to 1.97] {1.3 to 2.1} |
TPOLO |
59.18 [57.6 to 62.26] {56.5 to 67.77} |
974.05 [876.96 to 1177.65] {815.5 to 1294.9} |
1.45 [1.4 to 1.5] {1.35 to 1.6} |
TSCLO |
52.67 [50.74 to 57.81] {48.77 to 63.35} |
952.2 [881.88 to 1015.81] {832.75 to 1223} |
1.53 [1.46 to 1.64] {1.2 to 1.75} |
TIPLO |
50.46 [43.15 to 53.78] {39.77 to 55.91} |
690.18 [627.01 to 762.75] {552.95 to 835.85} |
1.25 [1.2 to 1.3] {1.1 to 1.35} |
Stat. (p-value) | 35.7 (< 0.0001) | 23.8 (0.0001) | 36.6 (< 0.0001) |
Data are summarized as median [Q1 to Q3] and {min to max}, where Q1 is the 25th percentile, Q3 is the 75th percentile, min is the minimum and max is the maximum value. C = Control group; T = Thrombosis group; TPOLO = Lavender oil Per Os group; TSCLO = SubCu-taneously Lavender Oil group; TIPLO = IntraPeritoneal Lavender Oil group; Stat. = the statistics of the Kruskal-Wallis test